Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BEAM Beam Therapeutics, Inc.

休市中 07-11 16:00:00 EDT

21.16

-0.87

-3.95%

盘后21.30

+0.14+0.66%

19:59 EDT

最高22.19	最低20.95	成交量229.90万
今开21.73	昨收22.03	日振幅5.63%
总市值21.28亿	流通市值19.26亿	总股本1.01亿
成交额4,931万	换手率2.53%	流通股本9,103万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BEAM","market":"US","secType":"STK","nameCN":"Beam Therapeutics, Inc.","latestPrice":21.16,"timestamp":1752264000000,"preClose":22.03,"halted":0,"volume":2298957,"hourTrading":{"tag":"盘后","latestPrice":21.3,"preClose":21.16,"latestTime":"19:59 EDT","volume":52639,"amount":1114106.4102,"timestamp":1752278341536},"delay":0,"floatShares":91026800,"shares":100557094,"eps":-4.58,"marketStatus":"休市中","change":-0.87,"latestTime":"07-11 16:00:00 EDT","open":21.73,"high":22.1899,"low":20.95,"amount":49308742.41267,"amplitude":0.056282,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.58,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1580965200000,"exchange":"NASDAQ","adjPreClose":22.03,"preHourTrading":{"tag":"盘前","latestPrice":21.7,"preClose":22.03,"latestTime":"09:29 EDT","volume":10146,"amount":219153.082554,"timestamp":1752240567003},"postHourTrading":{"tag":"盘后","latestPrice":21.3,"preClose":21.16,"latestTime":"19:59 EDT","volume":52639,"amount":1114106.4102,"timestamp":1752278341536},"volumeRatio":0.7882775754852793,"impliedVol":0.6671,"impliedVolPercentile":0.632},"requestUrl":"/m/hq/s/BEAM","defaultTab":"news","newsList":[{"id":"2549528354","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.06%报20.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549528354?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:37","pubTimestamp":1751981852,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时37分，Beam Therapeutics Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报20.15美元/股，成交量29.487万股，换手率0.29%，振幅4.30%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BK4139","BK4007","BK4588","LENZ","BK4611","BK4556","BEAM","BK4535","BK4505"],"gpt_icon":0},{"id":"1195291286","title":"Cathie Wood继续抛售Palantir，增持Beam Therapeutics和GitLab","url":"https://stock-news.laohu8.com/highlight/detail?id=1195291286","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195291286?lang=zh_cn&edition=full","pubTime":"2025-06-12 14:40","pubTimestamp":1749710400,"startTime":"0","endTime":"0","summary":"周三，Cathie Wood 的 Ark Invest 进行了多项重要交易，其中最引人注目的包括以下几家公司： $Beam Therapeutics, Inc.$ 、 $GitLab, Inc.$ 、 $Palantir Technologies Inc.$ 、 $Roblox Corporation$ 、 $克瑞拓斯安全防卫$ 、Cloudflare、 $CrowdStrike Holdings, Inc.$ 、 $CoreWeave, Inc.$ 和 $AvidXchange Holdings, Inc$ 。关于 $Beam Therapeutics, Inc.$ 的交易：Ark Invest 旗下的 ARK Innovation ETF买入了 349,264 股 Beam Therapeutics。关于 $Palantir Technologies Inc.$ 的交易：与买入 BEAM 和 GTLB 不同，Ark Invest 选择减持 $Palantir Technologies Inc.$ 的股票，减持行为发生在旗下的多个 ETF 中，包括 ARKK、ARK Autonomo","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","PLTR","GTLB"],"gpt_icon":1},{"id":"2535207423","title":"Beam Therapeutics Inc.盘中异动 临近午盘股价大跌5.04%报17.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535207423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535207423?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:40","pubTimestamp":1747237212,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时40分，Beam Therapeutics Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报17.14美元/股，成交量53.4024万股，换手率0.53%，振幅7.04%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423401297599e23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423401297599e23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4007","BK4139","BK4505","BK4588","BK4535","BK4539","BK4585","BEAM","LENZ","BK4611"],"gpt_icon":0},{"id":"2534233619","title":"Beam Therapeutics Inc.2025财年第一财季实现净利润-1.09亿美元，同比减少10.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534233619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534233619?lang=zh_cn&edition=full","pubTime":"2025-05-12 00:00","pubTimestamp":1746979249,"startTime":"0","endTime":"0","summary":"5月12日，Beam Therapeutics Inc.公布财报，公告显示公司2025财年第一财季净利润为-1.09亿美元，同比减少10.47%；其中营业收入为7.47百万美元，同比增加0.81%，每股基本收益为-1.24美元。从资产负债表来看，Beam Therapeutics Inc.总负债3.44亿美元，其中短期债务13.21百万美元，资产负债比为4.27，流动比率为8.79。机构评级：截至2025年5月12日，当前有16家机构对Beam Therapeutics Inc.目标价做出预测，其中目标均价为43.75美元，其中最低目标价为20.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000215a47a493c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000215a47a493c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BEAM"],"gpt_icon":0},{"id":"1157820864","title":"异动解读 | 基因编辑公司Beam Therapeutics盘中大涨8.17%，投资者看好其长期潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1157820864","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157820864?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:01","pubTimestamp":1746799287,"startTime":"0","endTime":"0","summary":"周五交易时段，基因编辑技术公司Beam Therapeutics股价出现显著上涨，盘中大涨8.17%，引发市场广泛关注。尽管近期面临分析师下调目标价的压力，但投资者似乎对该公司的长期发展前景保持乐观态度。Beam Therapeutics是一家专注于开发精准基因药物的生物技术公司，其核心技术是专有的碱基编辑技术。尽管巴克莱近期将Beam Therapeutics的目标价从31美元下调至25美元，但市场反应似乎与这一负面消息相悖。生物技术行业的整体上涨趋势也可能为BEAM股价提供了支撑。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 基因编辑公司Beam Therapeutics盘中大涨8.17%，投资者看好其长期潜力","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"2534304480","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534304480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534304480?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:34","pubTimestamp":1746797671,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时34分，Beam Therapeutics Inc.股票出现异动，股价急速上涨5.16%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。该信息摘要如下：巴克莱：维持Beam Therapeutics评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921343294f1d5a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921343294f1d5a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BEAM","BK4588","BK4611","BK4505","BK4585","LENZ","BK4535","BK4139","BK4556"],"gpt_icon":0},{"id":"2533938306","title":"巴克莱：维持Beam Therapeutics(BEAM.US)评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533938306","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533938306?lang=zh_cn&edition=full","pubTime":"2025-05-07 20:52","pubTimestamp":1746622342,"startTime":"0","endTime":"0","summary":"巴克莱：维持Beam Therapeutics(BEAM.US)评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07205250206786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BEAM","LENZ"],"gpt_icon":0},{"id":"2532174723","title":"Beam基金会：已于5月1日销毁逾1.1亿枚BEAM代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2532174723","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532174723?lang=zh_cn&edition=full","pubTime":"2025-05-04 20:42","pubTimestamp":1746362560,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/BeamFDN/status/1918980192598450501","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4585","BK4611","BK4505","BK4535","BK4556","BK4588","BEAM","BK4139"],"gpt_icon":0},{"id":"2529899446","title":"Beam Therapeutics Inc.盘中异动 快速拉升5.85%报20.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529899446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529899446?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415050,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分，Beam Therapeutics Inc.股票出现波动，股价急速拉升5.85%。截至发稿，该股报20.25美元/股，成交量3.2606万股，换手率0.03%，振幅0.00%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213051a6c53c18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213051a6c53c18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BEAM","LENZ","BK4535","BK4007","BK4556","BK4585","BK4611","BK4588"],"gpt_icon":0},{"id":"2529669534","title":"Beam Therapeutics Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529669534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529669534?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:02","pubTimestamp":1745337751,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时02分，Beam Therapeutics Inc.股票出现波动，股价大幅上涨5.04%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230002329740de7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230002329740de7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BEAM","BK4585","BK4535","BK4139","BK4588","LENZ","BK4007","BK4611","BK4505"],"gpt_icon":0},{"id":"2529002118","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.06%报17.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529002118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529002118?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:09","pubTimestamp":1745244551,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时09分，Beam Therapeutics Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报17.86美元/股，成交量19.0309万股，换手率0.19%，振幅6.61%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4535","BEAM","BK4588","BK4556","LENZ","BK4585","BK4007","BK4611"],"gpt_icon":0},{"id":"2527408246","title":"Beam Therapeutics Inc.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527408246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527408246?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:53","pubTimestamp":1744811592,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时53分，Beam Therapeutics Inc.股票出现异动，股价大幅下跌5.03%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4505","BK4556","BK4611","BK4585","BEAM","BK4535","BK4139","BK4588"],"gpt_icon":0},{"id":"2527164885","title":"Beam Therapeutics Inc.盘中异动 快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164885?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:31","pubTimestamp":1744637468,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分，Beam Therapeutics Inc.股票出现波动，股价快速拉升5.11%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421311094d50a29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421311094d50a29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","BEAM","BK4139","BK4588","BK4007","BK4535","BK4505","BK4556","BK4611"],"gpt_icon":0},{"id":"2518220291","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220291?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615383,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分，Beam Therapeutics Inc.股票出现异动，股价急速下跌5.20%。截至发稿，该股报27.00美元/股，成交量237.165万股，换手率2.83%，振幅3.72%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4505","BK4588","BK4535","BK4585","BEAM","LENZ","BK4611"],"gpt_icon":0},{"id":"2517200169","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517200169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517200169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271528,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Beam Therapeutics Inc.股票出现异动，股价大幅下挫5.09%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为953.51%、104.36%、48.88%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","BK4556","BK4535","BK4585","BEAM","LENZ","BK4139"],"gpt_icon":0},{"id":"2516670089","title":"Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670089?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099972,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Beam Therapeutics Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报23.80美元/股，成交量20.2093万股，换手率0.24%，振幅2.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","BK4588","BK4556","BEAM","BK4585","BK4535"],"gpt_icon":0},{"id":"2516619511","title":"数据：在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516619511","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516619511?lang=zh_cn&edition=full","pubTime":"2025-03-04 12:42","pubTimestamp":1741063374,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896779398776512797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["MKR.USD.CC","BK4556","BK4601","ETH","BEAM","BK4585","BK4535","BK4139","BK4588","ETH.USD.HKCC","BTCmain","XBTmain","MKR.USD.HKCC","BK4505","BTC","BTC.USD.HKCC"],"gpt_icon":0},{"id":"2516663938","title":"Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663938?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，Beam Therapeutics Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报24.99美元/股，成交量81.582万股，换手率0.97%，振幅6.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","LENZ","BK4505","BK4556","BK4588","BEAM","BK4139"],"gpt_icon":0},{"id":"2516786035","title":"某巨鲸以1.17美元均价增持534万枚ONDO，曾投资PEPE及BEAM亏损超1400万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516786035","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516786035?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:58","pubTimestamp":1740970730,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896388254917955585","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4505","BEAM","BK4535","BK4139","MKR.USD.HKCC","BK4556","BK4585","BK4588"],"gpt_icon":0},{"id":"2516341379","title":"Beam Therapeutics Inc.2024财年实现净利润-3.77亿美元，同比减少183.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516341379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:01","pubTimestamp":1740758461,"startTime":"0","endTime":"0","summary":"3月1日，Beam Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-3.77亿美元，同比减少183.46%；其中营业收入为63.52百万美元，同比减少83.20%，每股基本收益为-4.58美元。从资产负债表来看，Beam Therapeutics Inc.总负债3.70亿美元，其中短期债务13.47百万美元，资产负债比为2.99，流动比率为4.83。机构评级：截至2025年3月1日，当前有14家机构对Beam Therapeutics Inc.目标价做出预测，其中目标均价为48.43美元，其中最低目标价为24.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beamtx.com","stockEarnings":[{"period":"1week","weight":0.0575},{"period":"1month","weight":0.1828},{"period":"3month","weight":0.3678},{"period":"6month","weight":-0.1982},{"period":"1year","weight":-0.1824},{"period":"ytd","weight":-0.1468}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beam Therapeutics Inc.成立于2017年1月25日，是一家生物技术公司，致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物，其愿景是为患有严重疾病的患者提供终身治疗疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.020436},{"month":2,"riseRate":0.6,"avgChangeRate":0.123426},{"month":3,"riseRate":0,"avgChangeRate":-0.205206},{"month":4,"riseRate":0.5,"avgChangeRate":-0.128126},{"month":5,"riseRate":0.5,"avgChangeRate":0.074807},{"month":6,"riseRate":0.833333,"avgChangeRate":0.150103},{"month":7,"riseRate":0.5,"avgChangeRate":0.098942},{"month":8,"riseRate":0.4,"avgChangeRate":-0.006987},{"month":9,"riseRate":0.2,"avgChangeRate":-0.081345},{"month":10,"riseRate":0.4,"avgChangeRate":0.021253},{"month":11,"riseRate":0.8,"avgChangeRate":0.196147},{"month":12,"riseRate":0.4,"avgChangeRate":0.072364}],"exchange":"NASDAQ","name":"Beam Therapeutics, Inc.","nameEN":"Beam Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beam Therapeutics, Inc.,BEAM,Beam Therapeutics, Inc.股票,Beam Therapeutics, Inc.股票老虎,Beam Therapeutics, Inc.股票老虎国际,Beam Therapeutics, Inc.行情,Beam Therapeutics, Inc.股票行情,Beam Therapeutics, Inc.股价,Beam Therapeutics, Inc.股市,Beam Therapeutics, Inc.股票价格,Beam Therapeutics, Inc.股票交易,Beam Therapeutics, Inc.股票购买,Beam Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}